Healthcare: Cann(‘t)Trust? And, What’s Behind Gilead’s Latest Mega-Deal

<p style="margin-bottom: 10.0pt; line-height: 115%;"><span style= "font-size: 16.0pt; line-height: 115%; color: black;">Marijuana stock CannTrust has revealed its been growing pot in unlicensed rooms, calling into question its future as a cannabis leader. Also, here’s why Gilead Sciences’ CEO just inked a multibillion deal with Galapagos to develop drugs together.</span></p>